BioCentury
ARTICLE | Top Story

Ariad raises $300 million in follow-on

January 25, 2013 1:57 AM UTC

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) raised $300 million through the sale of 15.3 million shares at $19.60 in a follow-on underwritten by JPMorgan; Cowen; Jefferies; BMO Capital Markets; Leerink; RBC Capital Markets; and UBS. Ariad proposed the offering late Wednesday, when its share price was $19.85. ...